申请人:——
公开号:US20040236007A1
公开(公告)日:2004-11-25
Use of a polymer as a levelling agent or anti-cratering agent, said polymer comprising at least one fluorinated unit represented by formula 1, (Formula 1) wherein R?1
is a moiety represented by C
n?F
2n+1?-(CH
2?)
m?-, C
n?F
2n?-(CH
2?)
m?-, C
n?F
2n+1?-(CII
2?)
m?-(OCII
2?CIIR?5
)
p?-, C
n?F
2n?-(CH
2?
m?-(OCH
2?CHR?5
)
p′? C
n?F
2n+1?-(CII
2?)
m?-X-, AC
n?F
2n?-(CII
2?)
m?-X- &lgr;C
n?F
2n?-(CH
2?)
m?-(OCH
2?CHR?5
)
p?-X or AC
n?F
2n+1?-(CII
2?)
m?-(OCII
2?CIIR?5
)
p?-X-; wherein A=H, Cl, Br, I, a C
1-12? alkyl or a OC
1-12 ?alkyl, wherein 4≦n≦20,0≦m˜≦4 and 0≦p≦20, wherein X is a spacer moiety selected from the group consisting of esters, amides, sulphoamides, mercapto groups, poltyurethane groups and alkyl groups, wherein R?2
, is H, a metal moiety, an (alkyl)ammonium moiety or an alkyl group, C
n?F
2n+1?-(CII
2?)
m?-, AC
n?F
2n?-(CII
2?)
m?-C
n?F
2n+1?-(CII
2?)
m?-(OCII
2?CIIR?5
)
p?-, C
n?F
2n?-(CH
2?)
m?-(OCH
2?CHR?5
)
p′? C
n?F
2n+1?-(CH
2?)
m?-X-, C
n?F
2n?-(CH
2?)
m?-X-, AC
n?F
2n?-(CH
2?)
m?-(OCH
2?CHR?5
)
p?-X or C
n?F
2n+1?-(CH
2?)
m?-(OCH
2?CHR?5
)
p?-X-; wherein A=H, Cl, Br, I, C
1-12? alkyl or OC
1-12
alkyl, wherein 4≦n≦20, 0≦m≦4 and 0≦p≦20, wherein X is a spacer moiety selected from the group consisting of esters, amides, sulphoamides, mercapto groups, polyurethane groups and alkyl groups, wherein R?3
and R?4
are independently selected from the group consisting of H, alkyl-groups and phenyl-groups and wherein R?5
is H and/or methyl group.
1
一种聚合物作为匀染剂或防缩孔剂的用途,所述聚合物包含至少一个由式 1 表示的氟化单元,(式 1 其中 R?1
是由 C
n?F
2n+1?-(CH
2?)
m?-, C
n?F
2n?-(CH
2?)
m?-, C
n?F
2n+1?-(CII
2?)
m?-(OCII
2?CIIR?5
)
p?-, C
n?F
2n?-(CH
2?
m?-(OCH
2?CHR?5
)
p′?C
n?F
2n+1?-(CII
2?)
m?-X-, AC
n?F
2n?-(CII
2?)
m?-X- &lgr;C
n?F
2n?-(CH
2?)
m?-(OCH
2?CHR?5
)
p?-X 或 AC
n?F
2n+1?-(CII
2?)
m?-(OCII
2?CIIR?5
)
p?-X-; 其中 A=H, Cl, Br, I, a C
1-12?烷基或 OC
1-12?烷基,其中 4≦n≦20,0≦m˜≦4 和 0≦p≦20,其中 X 是选自由酯、酰胺、磺酰胺、巯基、聚氨酯基团和烷基组成的组的间隔基,其中 R?2
是 H、金属分子、(烷基)铵分子或烷基,C
n?F
2n+1?-(CII
2?)
m?-,AC
n?F
2n?-(CII
2?)
m?-C
n?F
2n+1?-(CII
2?)
m?-(OCII
2?CIIR?5
)
p?-, C
n?F
2n?-(CH
2?)
m?-(OCH
2?CHR?5
)
p′? C
n?F
2n+1?-(CH
2?)
m?-X-, C
n?F
2n?-(CH
2?)
m?-X-, AC
n?F
2n?-(CH
2?)
m?-(OCH
2?CHR?5
)
p?-X 或 C
n?F
2n+1?-(CH
2?)
m?-(OCH
2?CHR?5
)
p?-X-; 其中 A=H, Cl, Br, I, C
1-12? 烷基或 OC
1-12
烷基,其中 4≦n≦20、0≦m≦4 和 0≦p≦20,其中 X 是选自由酯、酰胺、磺酰胺、巯基、聚氨酯基团和烷基组成的组的间隔基,其中 R?3
和 R?4
独立选自 H、烷基和苯基组成的组,其中 R?5
是 H 和/或甲基。
1